- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02708810
RAD 1501: A Trial of Virtual Cone Trigeminal Neuralgia Radiosurgery
March 5, 2024 updated by: John Fiveash, MD, University of Alabama at Birmingham
RAD 1501: A Phase II Trial of Virtual Cone Trigeminal Neuralgia Radiosurgery
To determine the feasibility of frameless Virtual Cone trigeminal neuralgia radiosurgery at a single institution prior to multi-institutional enrollment.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
To determine the feasibility of frameless Virtual Cone trigeminal neuralgia radiosurgery at a single institution prior to multi-institutional enrollment.
To measure pain relief after Virtual Cone radiosurgery utilizing the Barrow Neurologic Institute Pain Intensity Score (BNI).
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Laronica K. Conway
- Email: laronicaconway@uabmc.edu
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35233
- Hazelrig-Salter Radiation Oncology Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 99 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients with trigeminal neuralgia pain that is not well controlled despite medical management (BNI 4 OR BNI 5)
- Patients must have an ECOG status of 0, 1, or 2
- Patients must be at least 18 years of age
- Life expectancy must be greater than 12 months
- MRI of brain within prior 12 months to confirm lack of other causes of facial pain
- All patients must be given written informed consent
Exclusion Criteria:
- Patients who have had prior brain radiosurgery or therapeutic radiation therapy to the pons
- Patients with atypical trigeminal neuralgia or headache pain syndromes
- Patients with pain associated with multiple sclerosis or base of skull tumor
- Patients with medical contra-indications to MR imaging (e.g. pacemaker)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: 80 Gy Radiation & Unframed Virtual Cone
80 Gy Virtual Cone Radiosurgery unframed (face mask)
|
A face mask (unframed) will be placed over the patient's face to keep their head from moving during the procedure.
This will allow for very precise targeting.
During the procedure, the study doctor will also confirm the exact location that needs to be treated using x-rays and optical imaging cameras.
The face mask (unframed) will hold the patient's head to prevent it from moving and to focus the x-rays and aim them on the painful nerve in the patient's brain.
For most patients, the actual time on the radiosurgery treatment machine is in the range of 30 to 60 minutes.
The face mask (unframed) will be removed after the treatment.
Other Names:
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feasibility of Frameless Virtual Cone Trigeminal Neuralgia Radiosurgery as assessed by number of participants that completed treatment
Time Frame: 3 Month Follow-Up Visit
|
3 Month Follow-Up Visit
|
|
The mean of Barrow Neurologic Institute Pain Intensity Score (BNI) (pain relief score) between the two arms.
Time Frame: 1 Year
|
Pain Relief Score designed to assess trigeminal neuralgia associated pain.
It ranges from "I" being "no trigeminal pain, no medication" to "V" being "severe pain/no pain relief".
|
1 Year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants with treatment-related adverse events
Time Frame: 1 Year
|
Based on the assessments of the patient and the responses provided by the patient in questionnaires, we will assess acute and late neurologic toxicities.
All adverse events/toxicities will be assessed with the utilization of CTCAE v.4.0.
|
1 Year
|
Mean of Quality of Life Scores as measured by SF-36 Questionnaire
Time Frame: 1 Year
|
Quality of Life (QOL) will be measured by SF-36.
This questionnaire consists of 36 questions (items) measuring physical and mental health in relation to 8 health concepts: physical functioning, bodily pain, role of limitations due to physical health problems, role of limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perception.
All items are scored so that a high score defines a more favorable health state.
Each item is scored on a 0 to 100 range so that the lowest and highest possible scores are set at 0 and 100, respectively.
|
1 Year
|
Patient Satisfaction Scores
Time Frame: 3 Month Follow-Up Visit
|
3 months following the completion of radiosurgery, the patient will be asked the following two questions: 1) Would you have the radiosurgery procedure again?
2) Would you recommend it to friends and family?
|
3 Month Follow-Up Visit
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: John Fiveash, MD, University of Alabama at Birmingham
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2015
Primary Completion (Estimated)
October 1, 2025
Study Completion (Estimated)
October 1, 2025
Study Registration Dates
First Submitted
November 16, 2015
First Submitted That Met QC Criteria
March 9, 2016
First Posted (Estimated)
March 15, 2016
Study Record Updates
Last Update Posted (Actual)
March 7, 2024
Last Update Submitted That Met QC Criteria
March 5, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-150608005
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Trigeminal Neuralgia
-
Klinikum Klagenfurt am WörtherseeUniversity of KlagenfurtCompletedGlossopharyngeal Neuralgia | Trigeminal Neuralgia, Idiopathic | Postherpetic; Neuralgia, Trigeminal (Etiology) | Atypical Facial PainAustria
-
Beijing Tiantan HospitalCompletedTrigeminal Neuralgia, SecondaryChina
-
University of FloridaFacial Pain Research FoundationCompleted
-
BiogenCompletedTrigeminal Neuralgia (TN) | Other Neuropathic PainUnited States
-
Ziekenhuis Oost-LimburgCompletedTrigeminal Neuralgia (TN)Belgium
-
Shifa Clinical Research CenterCompletedTrigeminal Neuralgia, Idiopathic
-
Vanderbilt University Medical CenterCompletedTrigeminal NeuralgiaUnited States
-
Seoul National UniversityRecruitingFacial Pain | Cluster Headache | Trigeminal Neuralgia | Postherpetic NeuralgiaKorea, Republic of
-
Beijing Tiantan HospitalBeijing Friendship Hospital; Beijing Ditan HospitalCompletedIdiopathic Trigeminal NeuralgiaChina
-
Danish Headache CenterRecruitingTrigeminal NeuralgiaDenmark
Clinical Trials on Unframed Virtual Cone
-
University of Alabama at BirminghamActive, not recruitingRAD 1601: EDGE Radiosurgery for Intractable Essential Tremor and Tremor-Dominant Parkinson's DiseaseParkinson Disease | Essential TremorUnited States
-
Medical University of South CarolinaNational Cancer Institute (NCI)Active, not recruitingSmoking Cessation | Lung Cancer ScreeningUnited States
-
University of AarhusCompletedCervical Dysplasia | Cervical Lesion | Cervix DiseaseDenmark
-
Centre Hospitalier Universitaire, AmiensActive, not recruiting
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaCompleted
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
University Hospital, BordeauxTerminated
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedRadiation Treatment for TumorsUnited States
-
Yasmine FouadCompletedAlveolar Ridge Preservation
-
Coloplast A/SMedPass InternationalCompleted